Open AccessPembrolizumab and Severe Hypertriglyceridemia Requiring Apheresis: An Immune-Related Adverse Event
Author(s) -
Malvi Thakker,
Kalimullah Quadri,
Ankuri Desai,
Wajiha Illyas,
Min Young Kim,
Sanket Desai,
Christina Rager
Publication year - 2019
Publication title -
journal of oncology practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.555
H-Index - 60
eISSN - 1935-469X
pISSN - 1554-7477
DOI - 10.1200/jop.19.00245
Subject(s) - medicine , pembrolizumab , adverse effect , hypertriglyceridemia , apheresis , intensive care medicine , plasmapheresis , immune system , immunology , immunotherapy , antibody , platelet , triglyceride , cholesterol
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom